Abstract
Background
Benzodiazepines and benzodiazepine-like sedatives (zopiclone, zolpidem and zaleplon) are commonly prescribed to treat anxiety and insomnia but are contraindicated for chronic use. We sought to study the persistence, over multiple years, of chronic use of benzodiazepines and benzodiazepine-like sedatives among community-dwelling adults in British Columbia, Canada.
Methods
This is a retrospective analysis of linked health data for adults aged 50 to 69 in 2004 who resided in British Columbia, Canada, between 2004 and 2013. We assigned subjects to one of four groups according to the total number of days of benzodiazepines and benzodiazepine-like sedatives that they were dispensed from retail pharmacies in each observation year. We estimated logistic regression models to measure associations between the odds of chronic sedative use and explanatory variables. We computed transition probability matrices that depict likelihood of changes in sedative utilization levels across years.
Results
Nearly one in ten (9.4%) community-dwelling older adults in British Columbia filled prescriptions with more than 90 days’ worth of benzodiazepines or benzodiazepine-like sedatives in 2013. The odds of such chronic sedative use were higher for people who were older, had lower income, were sicker, or lived in rural communities; odds were lower for people with Chinese or South Asian surnames and for men who were married. Controlling for other factors, chronic users of sedatives in 2008 were 15 times more likely than non-users of sedatives in 2008 to be chronic sedative users in 2013 (OR = 14.73; 95% CI = [14.24, 15.24]). Approximately two out of every five older British Columbians who were chronic sedative users in 2013 had been chronic users of sedatives 10 years prior. Two out of every three chronic sedative users in 2004 were either chronic users (57%) or dead (16%) by 2013.
Interpretation
Chronic use of sedatives is prevalent and persistent among older adults in British Columbia. The persistence of chronic sedative use between when patients were 50 to 59 years old and when they were 60 to 69 years old suggests that earlier interventions to curb chronic sedative use may be warranted even if patients do not experience significant risks until later ages.
Similar content being viewed by others
References
Donoghue J, Lader M (2010) Usage of benzodiazepines: a review. Int J Psychiatry Clin Pract 14(2):78–87. doi:10.3109/13651500903447810
Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns—a systematic review of register-based studies. Eur Psychiatry 30(8):1037–1047. doi:10.1016/j.eurpsy.2015.09.003
Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J (2008) Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 9(8):818–822. doi:10.1016/j.sleep.2007.11.011
Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47(1):30–39
American Geriatrics Society Beers Criteria Update Expert Panel (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. doi:10.1111/jgs.13702
Cunningham CM, Hanley GE, Morgan S (2010) Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. Health policy 97(2):122–129
Johnell K, Fastbom J (2009) The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. International Journal of Geriatric Psychiatry 24(7):731–738. doi:10.1002/gps.2189
Hoffmann F, Hies M, Glaeske G (2010) Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf 19(10):1071–1077. doi:10.1002/pds.2013
Alessi-Severini S, Bolton JM, Enns MW, Dahl M, Collins DM, Chateau D, Sareen J (2014) Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open 2(4):E208–E216. doi:10.9778/cmajo.20130076
Weymann D, Gladstone EJ, Smolina K, Morgan SG (2017) Long-term sedative use among community-dwelling adults: a population-based analysis. CMAJ Open 5(1):E52–E60. doi:10.9778/cmajo.20160056
Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ (2014) Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry 204(2):98–107. doi:10.1192/bjp.bp.113.126003
Daw JR, Morgan SG (2012) Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010. Health Policy 104(1):19–26. doi:10.1016/j.healthpol.2011.08.015
BC Ministry of Health [creator] (2015) Medical Services Plan (MSP) Payment Information File. Population Data BC [publisher]. Population Data BC [publisher] Data Extract. MOH (2014). http://www.popdata.bc.ca/data
BC Ministry of Health [creator] (2015) PharmaNet. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2014). http://www.popdata.bc.ca/data
Canadian Institute for Health Information [creator] (2015) Discharge Abstract Database (Hospital Separations). Population Data BC [publisher] Data Extract. MOH (2014). http://www.popdata.bc.ca/data
British Columbia (2014) What Is PharmaNet? Pharmacare, BC Ministry of Health. http://www.health.gov.bc.ca/pharmacare/pharmanet/netindex.html. Accessed July 7 2014
Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter. J Health Soc Behav 36(1):1–10
Phillips KA, Morrison KR, Andersen R, Aday LA (1998) Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res 33(3 Pt 1):571–596
Hanley GE, Morgan SG, Reid RJ (2010) Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada. Med Care 48(5):402–408. doi:10.1097/MLR.0b013e3181ca3d5d
Hanley G, Morgan S (2008) On the validity of area-based income measures to proxy household income. BMC Health Serv Res 8(1):79
Morgan SG, Hanley G, Cunningham C, Quan H (2011) Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data. Open Medicine 5(2):e87–93
Puyat JH, Hanley GE, Cunningham CM, Law MR, Wong ST, Sutherland JM, Morgan SG (2011) Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study. Psychiatr Serv 62(9):1–9
Morgan SG, Weymann D, Pratt B, Smolina K, Gladstone EJ, Raymond C, Mintzes B (2016) Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults. Age Ageing 45(4):535–542. doi:10.1093/ageing/afw074
Shah BR, Chiu M, Amin S, Ramani M, Sadry S, Tu JV (2010) Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med Res Methodol 10(1):42–42
British Columbia (2008) The diversity of visible minorities and ethnic origins in BC. Ministry of Attorney General and Minister Responsible for Multiculturalism, Victoria
Luijendijk HJ, Tiemeier H, Hofman A, Heeringa J, Stricker BHC (2008) Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol 65(4):593–599. doi:10.1111/j.1365-2125.2007.03060.x
Rikala M, Korhonen MJ, Sulkava R, Hartikainen S (2011) Psychotropic drug use in community-dwelling elderly people—characteristics of persistent and incident users. Eur J Clin Pharmacol 67(7):731–739. doi:10.1007/s00228-011-0996-5
Fang S-Y, Chen C-Y, Chang IS, Wu EC-H, Chang C-M, Lin K-M (2009) Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug Alcohol Depend 104(1–2):140–146. doi:10.1016/j.drugalcdep.2009.04.017
van Hulten R, Isacson D, Bakker A, Leufkens HG (2003) Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidem Dr S 12(1):49–53. doi:10.1002/pds.784
Jorm AF, Grayson D, Creasey H, Waite L, Broe GA (2000) Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 24(1):7–10. doi:10.1111/j.1467-842X.2000.tb00715.x
Morgan SG, Gladstone EJ, Weymann D, Khan N (2017) The effects of catastrophic drug plan deductibles on older women’s use of cardiovascular medicines: a retrospective cohort study. CMAJ Open 5(1):E198–E204. doi:10.9778/cmajo.20160145
Author information
Authors and Affiliations
Contributions
SM was responsible for project conception, acquisition of funding and data, study design, assisting with the interpretation of results and drafting of the manuscript. DW was responsible for data analysis, drafting sections of the manuscript and revising the manuscript for important intellectual content. All authors gave final approval of the version to be published and agreed to act as guarantors of the work.
Corresponding author
Ethics declarations
Ethics approval
The University of British Columbia’s Behavioural Research Ethics Board approved this study.
Competing interests
The declare authors that they have no competing interests.
Funding
This study was funded by the Canadian Institutes of Health Research. The funding body was not involved in the study design, analysis, interpretation of the data or writing of this manuscript.
Disclaimer
All inferences, opinions and conclusions drawn in this report are those of the authors and do not reflect the opinions or policies of Population Data BC or the data stewards.
Electronic supplementary material
ESM 1
(DOCX 24 kb)
Rights and permissions
About this article
Cite this article
Morgan, S.G., Weymann, D. Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada. Eur J Clin Pharmacol 73, 1001–1008 (2017). https://doi.org/10.1007/s00228-017-2253-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2253-z